Azenta Life Science
Azenta Life Science, headquartered in the United States, is a leading provider in the life sciences industry, specialising in sample management and genomic services. Founded in 2021, the company has quickly established itself as a key player, offering innovative solutions that streamline research and development processes for biopharmaceutical and academic institutions. With a focus on biobanking, sample logistics, and genomic analysis, Azenta Life Science distinguishes itself through its advanced technology and commitment to quality. The company’s core services include automated sample storage, data management, and comprehensive genomic services, all designed to enhance efficiency and accuracy in scientific research. Recognised for its robust market position, Azenta Life Science continues to achieve significant milestones, contributing to advancements in personalised medicine and drug discovery. Its dedication to innovation and customer satisfaction solidifies its reputation as a trusted partner in the life sciences sector.
DitchCarbon Score
How does Azenta Life Science's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Azenta Life Science's score of 47 is higher than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Azenta Life Science's reported carbon emissions
Azenta Life Sciences, headquartered in the United States, has set ambitious climate commitments aimed at significantly reducing its carbon emissions. Although specific emissions data for the most recent year is not available, the company has established a target to reduce its Scope 1 and Scope 2 greenhouse gas (GHG) emissions by 55% by 2033, using 2022 as the baseline year. This commitment reflects a long-term strategy to enhance sustainability within its operations. In addition to its short-term reduction targets, Azenta has committed to achieving net-zero emissions across all scopes by 2050. This commitment is part of the Science Based Targets initiative (SBTi), which underscores the company's dedication to aligning its climate actions with global climate goals. Overall, Azenta Life Sciences is actively working towards a more sustainable future through its significant emissions reduction targets and net-zero commitment, positioning itself as a responsible player in the pharmaceuticals, biotechnology, and life sciences sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 4,647,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 13,492,000 | 00,000,000 | 0,000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Azenta Life Science is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
